Dr. Gary E. Myerson, M.D., completed his Undergraduate Degree in Biology from Emory University in June 1973, subsequently earning his medical degree at the Far Eastern University, School of Medicine, in Manila, Philippines in 1977. Dr Myerson began his residency training at the Jewish Hospital and Medical Center of Brooklyn, in Brooklyn, New York in July of 1977. He was appointed Chief Resident during his third year, and completed the residency program in June of 1980. He conducted his Fellowship training at Emory University School of Medicine; Department of Internal Medicine; Division of Rheumatology-Immunology; July 1, 1980 through June 30, 1982. Dr. Myerson is Board Certified in Internal Medicine, sub-specialty, Rheumatology.

He has been in practice at the Arthritis and Rheumatology of Georgia, P.C., since 1982 and currently is affiliated with Northside and Saint Joseph’s Hospital’s in Atlanta, Georgia. Dr. Myerson has received several Honors and awards, including, Intern of the Year, Department of Medicine, June 1978, Jewish Hospital and Medical Center of Brooklyn; he was awarded with the position of Honorary Fellow of the Atlanta Craniomandibular Society, and he was selected as the Rheumatology Editor for The Journal of Craniomandibular Practice.

Dr. Myerson has held numerous professional positions and is currently part of Medical Staff, Team Rheumatologist for the Atlanta Falcons Football Club. He has participated in several invited lecture series, such as the American College of Rheumatology 2009 and 2007 Annual Meeting, “Meet the Professor” in Fibromyalgia, Innovative Theatre Sessions in Fibromyalgia, and “Meet the Professor” in Fibromyalgia, Moderator, Clinical Session “Interstitial Lung Disease in Rheumatic Diseases,” at the American College of Rheumatology 2006 Annual Meeting. He was also on the Planning Committee for Professional Meetings of the American College of Rheumatology, and served on the Professional Meetings Committee of the American College of Rheumatology for a number of years. Dr. Myerson currently has served on the Medical and Scientific Committee of the Arthritis Foundation, Georgia Chapter for over 13 years, and has been an active Member of the Board of Directors of the Lupus Foundation of America, Georgia Chapter for over 22 years.

Dr. Myerson is a Founding Fellow of the American College of Rheumatology, and is an active member of the Georgia Chapter of the Arthritis Foundation, the Georgia Chapter of the Lupus Foundation of America, the Sjogrens Syndrome Foundation, the Georgia Society of Rheumatology, the Medical Association of Atlanta, the Medical Association of Georgia, and the American College of Sports Medicine.

Dr. Myerson is the Principal Investigator or Investigator of 9 currently ongoing longitudinal or multi-phased/industry-sponsored clinical trials, e.g., “An open-label, randomized study to evaluate the safety, tolerability and efficacy of tocilizumab (TCZ) monotherapy or TCZ in combination with non-biologic DMARDs in patients with active rheumatoid arthritis who have an inadequate response to current non-biologic or biologic DMARDs” (Hoffman La Roche), and “A Phase 3, Randomized, Double Blind, Placebo-Controlled Study of the Safety and Efficacy of 2 Doses of CP-690,550 in Patients with Active Rheumatoid Arthritis on Background Methotrexate with Inadequate Response to TNF Inhibitors” (Pfizer). He has also played in integral role as an investigator in a number of funded clinical research trials that have been completed. Dr. Myerson has authored numerous chapters, articles and reviews and continues to present and lecture in his vast areas of rheumatologic expertise.